Skip to content
FIND A HEALTH VALLEY ACTOR

Friedrich Miescher Award

FMI

If your are a researcher in biochemistry, apply before 31 October 2025 for the Friedrich Miescher Award 2026   To commemorate the 100-year anniversary of the discovery of nucleic acids the Molecularand Cellular Biosciences section of Life Sciences Switzerland (formerly the Swiss Society for Molecular and Cellular Biosciences/Swiss Society for Biochemistry) has created the Friedrich…

Read More

CREAL Closes $8.9M Investment Round Led by ZEISS

CREAL

CREAL, the Vaud-Based innovator behind revolutionary light field display technology, announces the final closing of an $8.9 million equity funding round, led by ZEISS, with participation from new and existing investors, including members of the UBS private investor network.   CREAL’s latest investment round underscores the growing momentum around light field technology and its potential…

Read More

CleantechAlps Celebrates 15 Years of Accelerating Sustainability Innovation in Western Switzerland

15 ans cleantech alps

CleantechAlps, the regional hub for clean technologies in Western Switzerland, is marking 15 years of dedicated support to sustainability and cleantech innovation. Launched in 2010 by the cantons of Western Switzerland, the platform has become a strategic catalyst for collaboration, promotion, and development across the cleantech ecosystem in Switzerland and Europe.   From its inception,…

Read More

Parkinson’s Disease: How the First Affected Side Shapes the Course of Symptoms

Parkinson Unige

New research from the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) reveals that the side of the body where Parkinson’s disease first manifests plays a critical role in the development of non-motor symptoms such as cognitive decline, anxiety, and depression.   Parkinson’s disease, which affects over 10 million people globally, typically begins asymmetrically—impacting…

Read More

Lara Chavaz from HUG Wins Swiss Childhood Cancer Research Award

Swiss Childhood Cancer Research

The official award ceremony for the Swiss Childhood Cancer Research Prize took place in Bern on 18 June 2025, recognizing Lara Chavaz of the Geneva University Hospitals (HUG) for her outstanding contribution to pediatric oncology research. The CHF 35,000 prize honors innovative projects in basic research conducted at Swiss research institutes and hospitals.    …

Read More

Trends in Micro Nano

Trends Micro Nano

Trends in Micro Nano is organized on 9 September 2025 at HE-ARC, Neuchâtel   Switzerland is at the forefront of global research in micro and nanotechnology, so register for the Trends in Micro Nano event organized by HE-ARC in Neuchâtel. Discover the latest innovations and trends presented by the leading Swiss players in the field.…

Read More

Forum HES-SO

Forum HES-SO

The Forum HES-SO is taking place on 4 March 2026 at Beaulieu Lausanne   Aimed at final-year students in the fields of Engineering and Architecture, Economics and Services, Social Work and Health, the HES-SO Forum is the ideal opportunity to prepare for entry into the professional world. This event also allows companies to meet new…

Read More

UNIL Scientists Develop Innovative Method to Reverse Cellular Aging

Longevity

A team of researchers at the University of Lausanne (UNIL) has unveiled a groundbreaking approach to combat cellular aging using a non-genetic, chemical-based method. Published in EMBO Molecular Medicine, their study demonstrates how a short treatment with a specific combination of small molecules can rejuvenate aged human cells and extend lifespan in microscopic worms, opening…

Read More

Comphya Closes Oversubscribed CHF 7.5 Million Series A Round

Comphya

Comphya SA, a Vaud-based clinical-stage MedTech company pioneering the first implantable neurostimulation therapy for erectile dysfunction (ED) unresponsive to medication, announced the closing of an oversubscribed Series A financing round. Including the conversion of existing convertible loans, the round brings Comphya’s total equity raised to CHF 7.5 million (~USD 8.4 million).     “We are…

Read More

Hilo by Aktiia Received FDA 510(k) Clearance for its Blood Pressure Monitor Wristband

Aktiia

The CSEM spinoff Aktiia has received FDA 510(k) clearance for its over-the-counter cuffless blood pressure monitor, G0 Blood Pressure Monitoring System, also known as the Hilo Band. Thi wearable uses an optical sensor to collect data from one’s wrist.   The Hilo by Aktiia wrist wearable is one of a kind as it collects one’s blood…

Read More